… suppression and recovery, PSA levels, prostate volume, quality of life (QoL), and … study to
serve as a contemporary ADT benchmark for qualitative comparisons. A second phase 2 study …

… This phase 2 NRE cohort implemented key elements desired … study design of, the blinded,
randomized, phase 3 COMET-2 … to a phase 2 signal-seeking study, was an essential step in …

… In vitro and in vivo studies of prostate cancer and other solid tumors suggest that bortezomib
activity is … A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma. …

… study is the second trial showing the activity of AA in patients with castration-resistant
prostate cancer … under evaluation in two prospective randomized, phase III, placebo-controlled …

… Lu that target PSMA have shown good efficacy and low toxicity in a recent prospective phase
2 study 1 and in multiple retrospective studies in men with mCRPC.2, 3, 4, 5, 8, 9, 10, 11, 12…

… to metastatic castration-resistant prostate cancer. This phase 2 study provides evidence that
[ 177 … in men with metastatic castration-resistant prostate cancer, with greater activity but less …

… observed in prostate cancer (PCa) patients relapsing after a primary curative treatment [ …
from all patients before inclusion in the study. This study was approved by the ethics committee …

… in escalating above the current 20 Gy in 2 fraction dose level. The low PSA nadirs in this
study are similar to that reported in previous studies utilizing SBRT boosts and not dissimilar to …

… In placebo-controlled, phase 2 and 3 clinical trials in patients with asymptomatic or
symptomatic. metastatic HRPC, atrasentan delayed disease progression and PSA progression, …

… Many studies have been conducted on the use of RT for PSA-only recurrence following RP.
As confirmed by various studies, the preradiation PSA level is critically important for optimal …